Macular pigment density variation after supplementation of lutein and zeaxanthin using the Visucam® 200 pigment module: Impact of age-related macular degeneration and lens status.
J Fr Ophtalmol
; 40(4): 303-313, 2017 Apr.
Article
en En
| MEDLINE
| ID: mdl-28336284
ABSTRACT
PURPOSE:
To assess the evolution of macular pigment optical density (MPOD) following supplementation with various macular formulations obtained with the Visucam® 200, and to study the factors affecting MPOD measurements. MATERIALS ANDMETHODS:
In this prospective, randomized, double-masked multicenter study, patients were divided into 2 groups group A (patients without retinal pathology who underwent cataract surgery 1 month previously) and group B (patients with neovascular age-related macular degeneration [AMD] in one eye). In each group, half of the patients were randomly assigned to receive a food supplementation either with or without carotenoids (5mg of Lutein and 1mg of Zeaxanthin). Outcome measures included MPOD responses obtained with the Visucam® 200 for one year.RESULTS:
In total, 126 subjects (52 men, 74 women) with a mean age of 75.3±7.61 years were enrolled. Mean MPOD values at the time of inclusion were statistically lower in group A (0.088 density unit [DU]) compared to group B (0.163 DU, P<0.05). No statistically significant increase in MPOD was noted in either group, even after discontinuation of the supplementation. By multiple regression analysis, age, female gender, lens status and the presence of AMD seemed to significantly affect MPOD measurements.CONCLUSION:
No significant improvement in MPOD seems to be detected with the Visucam® 200 after carotenoid supplementation. The MPOD measurement seems to be highly affected by cataract extraction and the presence of AMD.Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Luteína
/
Imagen Óptica
/
Zeaxantinas
/
Pigmento Macular
/
Cristalino
/
Degeneración Macular
Tipo de estudio:
Clinical_trials
/
Diagnostic_studies
Límite:
Aged
/
Aged80
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
J Fr Ophtalmol
Año:
2017
Tipo del documento:
Article